NEW YORK, Sept. 24, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Greenway Medical Technologies, Inc. ("Greenway" or the "Company") (NYSE: GWAY) (ISIN: US39679B1035) (CUSIP: 39679B103) concerning the proposed......
More...
